Dr. Nizar Chafic Charafeddine, MD

Dr. Charafeddine practices at TriHealth's Good Samaritan Hospital in Cincinnati, Ohio, part of TriHealth.

Dr. Charafeddine's NPI, 1912090317, was assigned on September 30, 2006. Dr. Charafeddine graduated from American University of Beirut Faculty of Medicine in 1989. Dr. Charafeddine holds Texas license K6821.

Dr. Charafeddine's primary practice is TriHealth's Good Samaritan Hospital, at 375 Dixmyth Avenue, Cincinnati, OH 45220 in Hamilton County. The practice phone is (513) 862-2601.

Dr. Charafeddine's primary practice is TriHealth's Good Samaritan Hospital in Cincinnati, Ohio, part of TriHealth. Dr. Charafeddine is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is TriHealth. Dmand AI also links Dr. Charafeddine to 1 more hospital, 4 medical groups, 2 physician offices and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Charafeddine practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Charafeddine's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Charafeddine is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Charafeddine's licenses on file in 9 states: Texas, Ohio, Nebraska, Tennessee, Alabama, Indiana, Illinois, Connecticut and Maryland.

Dmand AI lists acid reflux, chronic indigestion, chronic inflammatory bowel disease (IBD), colonoscopy, gastroduodenitis, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Charafeddine treats.

CMS data shows 523 Medicare services from Dr. Charafeddine across 11 procedure codes in 2024, for 276 Medicare patients. Medicare paid $49,719 for them.

CMS counts 276 Medicare patients who saw Dr. Charafeddine in 2024. The largest group is 65 to 74, with 117 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Charafeddine's median patient age at 69, with 58% women.

In 2024, Dr. Charafeddine wrote 523 Medicare Part D claims for 168 patients. 78% of them were for generic drugs. CMS names the drug for 355 of them, across 9 drugs with 11 or more claims each, at $55,498 in total drug cost. In 2023, CMS named 672 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Charafeddine for performance year 2024, reported through an alternative payment model (APM). Dr. Charafeddine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Charafeddine as offering telehealth. CMS counts 88 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Charafeddine, more than 74% of the clinicians it reports for that procedure.

CMS Open Payments shows 303 general payments to Dr. Charafeddine from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Abbvie Inc. paid the most, $1,703.

Dmand AI lists 3 awards for Dr. Charafeddine, most recently CMS Stage 1 2012 in 2012.

Dr. Charafeddine graduated from American University of Beirut Faculty of Medicine in 1989. Dr. Charafeddine is a member of ACG.

Dr. Charafeddine is in network with 24 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.